Funding Cut by Trump Administration Halts Development of Life-Saving Baby Heart Device

In a concerning development for pediatric cardiology, a promising project aimed at assisting infants with severe heart defects has abruptly lost its vital funding. The initiative, centered around the PediaFlow device—a compact, battery-sized pump designed to improve blood circulation—was awarded $6.7 million by the U.S. Department of Defense (DoD) on March 30 to support its production and testing phases. However, just days after the grant approval, the DoD issued a stop-work order, effectively halting further progress. This decision has been linked to the current administration's directives, and neither the Department of Defense nor the White House provided specific comments. The project, led by biomedical engineering Professor James Antaki at Cornell University, seeks to refine a device that could significantly improve survival rates for babies born with critical heart conditions. Currently, about one in every 100 babies in the United States is born with heart defects, with approximately 25% requiring surgical intervention within their first year, according to the CDC. The PediaFlow device has shown promise since its development began in 2003, with Antaki and his team planning to conduct further animal testing and prepare FDA documentation, which would have been supported by the canceled funds. The loss of financial backing is a setback not only for the project but potentially for many infants awaiting innovative treatments. Pediatric cardiologist Dr. Evan Zahn emphasized the importance of such technology, noting the urgent need for specialized devices designed specifically for children. If the funding is not reinstated within 90 days, the project's team may be forced to lay off staff and alter their research focus, delaying crucial advancements. Advocates argue that investing in pediatric medical innovations like PediaFlow is essential, highlighting the device's potential to save numerous young lives. The situation underscores ongoing challenges in securing consistent federal support for pediatric medical research.

(Source: https://medicalxpress.com/news/2025-05-trump-administration-funding-life-baby.html)